On this page
DKC1
dyskerin pseudouridine synthase 1
The DKC1 gene provides instructions for producing dyskerin, a protein vital for maintaining telomere stability and ribosomal RNA production, impacting cell division and overall cellular health. DKC1 plays a crucial role in maintaining telomeres, the protective caps at the ends of chromosomes, and in the synthesis of ribosomal RNA.
DKC1 is located on the long (q) arm of chromosome X, at band Xq28. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
The DKC1 gene encodes the dyskerin protein, which is integral to several fundamental cellular processes. Dyskerin is primarily known for its role in maintaining telomeres, the protective structures found at the ends of chromosomes. These telomeres are crucial for safeguarding genomic integrity by preventing chromosomes from fusing or degrading.
Beyond telomere maintenance, the dyskerin protein also participates in the production of ribosomal RNA (rRNA), which is essential for assembling proteins within cells. Disruptions in DKC1 function are linked to conditions characterised by impaired cellular function, particularly in tissues with high cell turnover.
What the gene does
The dyskerin protein, encoded by the DKC1 gene, performs two critical functions within the cell: telomere maintenance and ribosomal RNA (rRNA) processing. Telomeres, located at the ends of chromosomes, shorten with each cell division, eventually signalling the cell to stop dividing or undergo programmed cell death. Dyskerin contributes to counteracting this shortening by interacting with telomerase, an enzyme complex that adds DNA repeats to telomere ends.
Specifically, dyskerin stabilises the hTR component of the telomerase complex, which acts as a template for adding these DNA sequences. This is particularly important in cells that divide frequently, such as those in bone marrow, the gastrointestinal tract, and developing foetal tissues. Additionally, dyskerin is involved in the biogenesis of rRNA, which is a key component of ribosomes, the cellular machinery responsible for protein synthesis.
Video: Genetics 101
Chromosome location
The DKC1 gene is located on the X chromosome at position Xq28. This chromosomal region is situated near the end of the long arm of the X chromosome. Given its X-linked location, genetic conditions linked to DKC1 typically follow an X-linked inheritance pattern.
Protein structure
The dyskerin protein, composed of 514 amino acids, contains several distinct functional regions. The Nucleolar localization region spans amino acids 2-21, facilitating its transport to the nucleolus, where rRNA processing occurs. A PUA domain is found between amino acids 296 and 371; PUA domains are known to bind RNA. The protein also features a Disordered region from amino acids 443-514. Furthermore, a Nuclear and nucleolar localization region is identified within amino acids 446-514, indicating its dual localisation within both the nucleus and the nucleolus.
Key variants
Variants within the DKC1 gene can alter the function of the dyskerin protein, leading to cellular dysfunction. These changes can affect the protein's ability to maintain telomere length or properly process ribosomal RNA. The severity and specific manifestations of conditions associated with DKC1 variants can vary depending on the nature and location of the genetic alteration.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1058C>T | p.Ala353Val | Pathogenic | ★★☆☆ | Dyskeratosis congenita |
c.146C>T | p.Thr49Met | Pathogenic | ★★☆☆ | Dyskeratosis congenita |
c.196A>G | p.Thr66Ala | Pathogenic/Likely pathogenic | ★★☆☆ | Dyskeratosis congenita |
c.1156G>A | p.Ala386Thr | Pathogenic | ★☆☆☆ | Dyskeratosis congenita, X-linked |
c.1345C>G | p.Arg449Gly | Pathogenic | ★☆☆☆ | not provided |
c.189T>G | p.Asn63Lys | Pathogenic | ★☆☆☆ | Dyskeratosis congenita |
c.203A>G | p.His68Arg | Pathogenic | ★☆☆☆ | Dyskeratosis congenita, X-linked |
c.5_7del | p.Ala2del | Pathogenic | ★☆☆☆ | Dyskeratosis congenita |
c.969T>A | p.Tyr323Ter | Pathogenic | ★☆☆☆ | Dyskeratosis congenita |
c.616G>A | p.Glu206Lys | Pathogenic | - | Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1 |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the DKC1 gene are primarily associated with Dyskeratosis congenita (X-linked), a rare inherited disorder. This condition is characterised by a classic triad of symptoms including skin pigmentation changes, nail dystrophy, and white patches in the mouth. Individuals with Dyskeratosis congenita also have an increased risk of developing other serious health issues, including bone marrow failure and certain cancers.
Inheritance pattern
Conditions caused by pathogenic DKC1 variants typically follow x-linked inheritance.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
UK clinical status
The DKC1 gene is recognised within the UK's NHS Genomic Medicine Service, featuring in several diagnostic panels. It holds a 'green' status on PanelApp for numerous indications, signifying strong evidence for its gene-disease association. These include panels for Ataxia and cerebellar anomalies - childhood onset, Cytopenias and congenital anaemias, Familial pulmonary fibrosis, and Haematological malignancies cancer susceptibility, among others. This widespread inclusion underscores its clinical relevance in diagnosing a range of inherited conditions.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the DKC1 gene?
The DKC1 gene is responsible for producing the dyskerin protein, which plays two main roles: maintaining the length of telomeres at the ends of chromosomes and assisting in the production of ribosomal RNA (rRNA) for protein synthesis.
What condition is most commonly associated with DKC1 variants?
Pathogenic variants in the DKC1 gene are most commonly associated with X-linked Dyskeratosis congenita. This inherited disorder affects various body systems, particularly those with rapidly dividing cells.
Why is telomere maintenance important for health?
Telomeres protect the ends of chromosomes from damage and degradation during cell division. Maintaining telomere length is crucial for preserving genomic stability and ensuring proper cell function, especially in tissues with high cell turnover.
References
- Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert review of hematology. 2013. PMID: 23782086
- Dokal I. Dyskeratosis congenita. Hematology. American Society of Hematology. Education Program. 2011. PMID: 22160078
- Rostamiani K, Klauck SM, Heiss N. Novel mutations of the DKC1 gene in individuals affected with dyskeratosis congenita. Blood cells, molecules & diseases. 2010. PMID: 19879169
- Nishio N, Kojima S. Recent progress in dyskeratosis congenita. International journal of hematology. 2010. PMID: 20882440
- Montanaro L. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer. The Journal of pathology. 2010. PMID: 20925138
- Gu B, Bessler M, Mason PJ. Dyskerin, telomerase and the DNA damage response. Cell cycle (Georgetown, Tex.). 2009. PMID: 19106610
- Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenita. British journal of haematology. 2009. PMID: 19208095
- Kirwan M, Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochimica et biophysica acta. 2009. PMID: 19419704
- Vulliamy TJ, Dokal I. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie. 2008. PMID: 17825470
- Kirwan M, Dokal I. Dyskeratosis congenita: a genetic disorder of many faces. Clinical genetics. 2008. PMID: 18005359